DHX58 and neoplasm: In the current study, RLR activation was used long enough prior to the induction of cell death by alpha radiation to allow the potential enhancement of antigen presentation on tumor cells, which may be crucial for achieving antigen-specific antitumor immunity in low-immunogenic tumors.